Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with the most up-to-date perspective on the company’s standing.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with the latest insights into its performance and outlook.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Arvee Laboratories (India) Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to positive, with significant growth in net sales and profit after tax (PAT), signalling a potential turnaround amid a challenging market environment.

Arvee Laboratories (India) Ltd., a micro-cap specialised chemicals manufacturer with a market capitalisation of ₹174.00 crores, reported a sequential recovery in profitability for Q4 FY26, though the numbers reveal concerning underlying trends that continue to plague the Ahmedabad-based company. Net profit stood at ₹0.52 crores for the March quarter, marking a sharp 71.58% decline from the exceptional ₹1.83 crores reported in Q3 FY26, but representing a substantial 642.86% year-on-year improvement from the mere ₹0.07 crores in Q4 FY25.

At Rs 147.15, sellers were still queuing — but there were no buyers willing to take the other side. Arvee Laboratories (India) Ltd locked at its lower circuit of 10% on 18 May 2026, with unfilled sell orders and a frozen price.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 Feb 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals and market performance.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with the latest insights into its performance and outlook.

At Rs 186.19, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Arvee Laboratories (India) Ltd locked at its upper circuit of 6.28% on 10 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 169.27, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Arvee Laboratories (India) Ltd locked at its upper circuit of 5.59% on 9 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 153.89, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Arvee Laboratories (India) Ltd locked at its upper circuit of 10% on 8 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with the latest insights into its performance and outlook.

At Rs 147.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Arvee Laboratories (India) Ltd locked at its upper circuit of 10%% on 30 Mar 2026, with buyers queuing and no sellers willing to part with shares.

Arvee Laboratories (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with the latest insights into its performance and outlook.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 17 Mar 2026, closing at ₹147.07, down 5.0% from the previous close. The stock faced intense selling pressure, with panic selling and unfilled supply driving the maximum permissible daily loss, signalling a sharp negative sentiment among investors in the Chemicals & Petrochemicals sector.